For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Healing & Recovery

SNAP-8

Also known as: Acetyl Octapeptide-3

SNAP-8 is a topical cosmetic peptide derived from SNAP-25, marketed as an alternative to topical Argireline for expression-line reduction.

Real-time market data

Pricing for SNAP-8

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Independent evidence

COAs for SNAP-8

25 third-party tests across 11 vendors. Each card links to the full report.

All 25 COAs for SNAP-8 →
Measured purity 96.9%–99.9% across 17 COAs
Measured purity over time
Aggregated · 3rd-party listing
99.80 %
Jun 2026
Janoshik Analytical

For

SNAP-8

by Verified Peptides· batch SN806260510E

Aggregated · 3rd-party listing
99.53 %
May 2026
ILS Labs

For

Snap-8

by Ion Peptide· batch SNP10-05042026

Aggregated · 3rd-party listing
99.74 %
May 2026
ILS Labs

For

Snap-8

by Ion Peptide· batch SNP8-04302026

Aggregated · 3rd-party listing
96.90 %
May 2026
Freedom Diagnostics

For

Snap-8

by Real Peptides· batch Black Cap

Aggregated · 3rd-party listing
99.60 %
Apr 2026
Biogenica Labs · HPLC

For

SNAP-8

by Amino Club· batch SN0001

Aggregated · 3rd-party listing
99.82 %
Feb 2026
Janoshik Analytical · HPLC

For

SNAP-8

by Qihang Peptide· batch 2

Aggregated · 3rd-party listing
98.68 %
Nov 2025
Chromate · HPLC

For

SNAP-8

by Mile High Compounds· batch SNA-010-MH-01

Aggregated · 3rd-party listing
98.72 %
Oct 2025
Vanguard Laboratory

For

Snap-8

by Certified Peptides· batch SNP10102325

Aggregated · 3rd-party listing
99.94 %
Oct 2025
Freedom Diagnostics

For

SNAP-8

by Ion Peptide· batch SN1-1025

Aggregated · 3rd-party listing
99.86 %
Sep 2025
Janoshik Analytical · HPLC

For

SNAP-8

by Skye Peptides· batch SN25-20-001

Aggregated · 3rd-party listing
99.75 %
Aug 2025
Janoshik Analytical · HPLC

For

SNAP-8

by Verified Peptides· batch 07-25-0310C

Aggregated · 3rd-party listing
99.69 %
Apr 2025
MZ Biolabs · HPLC

For

SNAP-8

by Profound Aminos· batch 2025-04-03

Aggregated · 3rd-party listing
99.81 %
Apr 2025
Janoshik Analytical · HPLC

For

SNAP-8

by Verified Peptides· batch 04-25-0210B

Aggregated · 3rd-party listing
99.63 %
Dec 2024
Janoshik Analytical · HPLC

For

SNAP-8

by Verified Peptides· batch cmojb4ql100pqkirx4ix88x77

Aggregated · 3rd-party listing
99.57 %
Sep 2024
Janoshik Analytical · HPLC

For

SNAP-8

by Peptide Tech· batch cmpac5zgg001btmrxtx7z0bzl

Aggregated · 3rd-party listing
99.83 %
Aug 2024
Janoshik Analytical · HPLC

For

SNAP-8

by Hydro Research Peptides· batch Snap8-6066

Aggregated · 3rd-party listing
99.63 %
Aug 2022
MZ Biolabs · HPLC

For

SNAP-8

by Hydro Research Peptides· batch 2024-08-05

Aggregated · 3rd-party listing
99.96 %
Freedom Diagnostics

For

SNAP-8

by Riptide Wellness· batch RWSNP-10-1001

Aggregated · 3rd-party listing
May 2026

Purity not on file

ILS Labs

For

Snap-8

by Ion Peptide· batch SNP6-04302026

Aggregated · 3rd-party listing
Oct 2025

Purity not on file

Janoshik Analytical

For

SNAP-8

by Skye Peptides· batch SN25-20-001

Aggregated · 3rd-party listing
Sep 2025

Purity not on file

Janoshik Analytical

For

SNAP-8

by Skye Peptides· batch SN25-10-001

Aggregated · 3rd-party listing
Aug 2025

Purity not on file

Janoshik Analytical

For

SNAP-8

by Verified Peptides· batch 07-25-0310C

Aggregated · 3rd-party listing
Dec 2024

Purity not on file

Janoshik Analytical

For

SNAP-8

by Verified Peptides· batch cmojb4qqf00prkirxexyzdm4u

Aggregated · 3rd-party listing
Aug 2024

Purity not on file

Janoshik Analytical

For

SNAP-8

by Hydro Research Peptides· batch Snap8-6066

Research depth

13 citations indexed for SNAP-8

All research on SNAP-8 →

cohort · 2026

Filtered-phase imaging versus susceptibility-weighted imaging for paramagnetic rim lesion detection in multiple sclerosis: A head-to-head comparison

Background Paramagnetic rim lesions (PRLs) detected on susceptibility-sensitive magnetic resonance imaging (MRI) represent chronic active lesions and correlate with disease progression in multiple sclerosis (MS). However, optimal detection methods remain unclear.

Study · 2026

An Experimental Measurement Method to Characterize and Apply Platinum Silicon Material for a Biomechanical Replica of the Thoracic Aorta

Currently, silicone is a common material used in medical research and biomedical applications. This research aims to characterize extra-soft platinum silicone (shore A 00 50) and compare its mechanical behavior with that of the human thoracic aorta.

case-report · 2026

Hereditary Neuropathy with Liability to Pressure Palsies Mimicking a Chronic Inflammatory Demyelinating Polyneuropathy Variant: A Case Report Highlighting Diagnostic Challenges

We herein report a case of chronic inflammatory demyelinating polyneuropathy (CIDP) that was ultimately identified as hereditary neuropathy with liability to pressure palsies (HNPP) based on PMP22 gene testing.

Study · 2025

Glycosylated <i>N</i>‑Acyl Phosphoethanolamines as Bacterial Food-Dependent Signaling Molecules in <i>Caenorhabditis</i> Nematodes

N -acyl ethanolamines represent conserved lipophilic signaling molecules that function as endogenous ligands at G-protein-coupled receptors, ion channels, and nuclear receptors.

Study · 2025

Ten Items to Find Them All: Shortening Scales for the Screening of Executive Function in Children With Attention Deficit/Hyperactivity Disorder

Background Attention Deficit/Hyperactivity Disorder (ADHD) is the most common neurodevelopmental disorder. The affectation of executive functions is stressed in the most recent research on ADHD, and many tests are used to assess it in ADHD, but they are usually time- and effort-consuming.

review · 2025

Home Sleep Apnoea Testing: Advances, Challenges and Considerations in Heart Failure

Sleep-disordered breathing (SDB), including obstructive and central sleep apnoea, is highly prevalent in heart failure (HF) and contributes to adverse outcomes. In-lab polysomnography is the diagnostic gold standard, but is limited by cost and accessibility.